Rita J Desai

Array ( [id] => 8842056 [patent_doc_number] => 20130137684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'HAEMATOPOIETIC-PROSTAGLANDIN D2 SYNTHASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/701380 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18097 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8755213 [patent_doc_number] => 20130089518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'NOVEL PYRIMIDINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/697954 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34296 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8697821 [patent_doc_number] => 20130059830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/696831 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31731 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571766 [patent_doc_number] => 08338412 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Inhibitors of P38' [patent_app_type] => utility [patent_app_number] => 13/107802 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16319 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13107802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090585 [patent_doc_number] => 20110218187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'INHIBITORS OF TYROSINE KINASES' [patent_app_type] => utility [patent_app_number] => 13/106582 [patent_app_country] => US [patent_app_date] => 2011-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27919 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218187.pdf [firstpage_image] =>[orig_patent_app_number] => 13106582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587384 [patent_doc_number] => 20110281894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'HEMIFUMARATE SALT' [patent_app_type] => utility [patent_app_number] => 13/105569 [patent_app_country] => US [patent_app_date] => 2011-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9704 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281894.pdf [firstpage_image] =>[orig_patent_app_number] => 13105569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8756033 [patent_doc_number] => 20130090338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS' [patent_app_type] => utility [patent_app_number] => 13/696860 [patent_app_country] => US [patent_app_date] => 2011-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31910 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10851065 [patent_doc_number] => 08877745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments' [patent_app_type] => utility [patent_app_number] => 13/696859 [patent_app_country] => US [patent_app_date] => 2011-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42142 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587383 [patent_doc_number] => 20110281893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'COMPOUND, SYNTHESIS, COMPOSITION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/103174 [patent_app_country] => US [patent_app_date] => 2011-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9433 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281893.pdf [firstpage_image] =>[orig_patent_app_number] => 13103174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063517 [patent_doc_number] => 20110245266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'PYRIDIN-2-ONE COMPOUNDS AND THEIR USE AS MODULATORS OF THE DOPAMINE D3 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 13/103734 [patent_app_country] => US [patent_app_date] => 2011-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16113 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245266.pdf [firstpage_image] =>[orig_patent_app_number] => 13103734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8842081 [patent_doc_number] => 20130137709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'Compounds that modulate EGFR activity and methods for treating or preventing conditions therewith' [patent_app_type] => utility [patent_app_number] => 13/695765 [patent_app_country] => US [patent_app_date] => 2011-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 33256 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9483133 [patent_doc_number] => 08729084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-20 [patent_title] => 'Benzofuranyl analogues as GPR119 modulators' [patent_app_type] => utility [patent_app_number] => 13/696131 [patent_app_country] => US [patent_app_date] => 2011-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30916 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8784730 [patent_doc_number] => 08431573 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-30 [patent_title] => 'Cyanopyrimidinones' [patent_app_type] => utility [patent_app_number] => 13/099064 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15725 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13099064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278510 [patent_doc_number] => 20120172382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES' [patent_app_type] => utility [patent_app_number] => 13/098247 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21223 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13098247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501583 [patent_doc_number] => 20110263541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'KINASE INHIBITORS AND THEIR USE AS PHARMACEUTICAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/095526 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 40738 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263541.pdf [firstpage_image] =>[orig_patent_app_number] => 13095526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386196 [patent_doc_number] => 08263590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Pyrimidine derivatives' [patent_app_type] => utility [patent_app_number] => 13/095760 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60460 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13095760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063595 [patent_doc_number] => 20110245232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS I' [patent_app_type] => utility [patent_app_number] => 13/071753 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33945 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245232.pdf [firstpage_image] =>[orig_patent_app_number] => 13071753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8784746 [patent_doc_number] => 08431589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-30 [patent_title] => '2,4-diaminopyrimidine derivatives' [patent_app_type] => utility [patent_app_number] => 13/069816 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12554 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13069816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113623 [patent_doc_number] => 20110190328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'ACID ADDITION SALTS OF (3,5-BIS TRIFLUOROMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3YL-PYRIMIDIN-2YLAMINO)-PHENYL]-BENZAMIDE' [patent_app_type] => utility [patent_app_number] => 13/053908 [patent_app_country] => US [patent_app_date] => 2011-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3064 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190328.pdf [firstpage_image] =>[orig_patent_app_number] => 13053908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791624 [patent_doc_number] => 20120053180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'CYCLOHEXANE ANALOGUES AS GPR119 AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/050801 [patent_app_country] => US [patent_app_date] => 2011-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23544 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053180.pdf [firstpage_image] =>[orig_patent_app_number] => 13050801 [rel_patent_id] =>[rel_patent_doc_number] =>)